Contact

Bound Therapeutics | News | Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics

Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics

October 30, 2017

Written by

Original Source

Contact

info@boundtherapeutics.com

Share it

Others Press Release

September 29, 2025

Bound Therapeutics Closes First Round of Pre-Seed Financing, Bringing Total Funding to $3.4M

June 14, 2019

RNA Blockade to Treat Triple Negative Breast Cancer

News
September 10, 2018

Bound Therapeutics is selected as a finalist in the UC Science Center QED proof-of-concept program

News